Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
238
datasets available to search
ShareScore release 0.9.0
Dataset results
238 results for “Lung Cancer Screening”
Screening for Lung Cancer in the HIV Patient
ClinicalTrials.gov study NCT01748136. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening
ClinicalTrials.gov study NCT06021652. IPD Sharing: NO. Countries: 0. Publications: 0.
A Randomized Controlled Trial Evaluating the Effectiveness of a Novel Risk-Stratified Screening Strategy for Lung Cancer
ClinicalTrials.gov study NCT07078032. IPD Sharing: NO. Countries: 0. Publications: 0.
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
ClinicalTrials.gov study NCT06775002. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Lung Cancer Screening CT for Firefighters
ClinicalTrials.gov study NCT06836414. IPD Sharing: NO. Countries: 1. Publications: 0.
Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening
ClinicalTrials.gov study NCT00607425. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures
ClinicalTrials.gov study NCT05900544. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States
ClinicalTrials.gov study NCT05024955. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Genome-wide screening of genomic alterations and transcriptional modulation in non-smoking female lung cancer in Taiwan
GEO Series GSE33356. Homo sapiens. 242 samples. Type: Genome variation profiling by SNP array; Expression profiling by array; SNP genotyping by SNP array.
An in vivo screening platform using PDX models reveals KEAP1, USP22 and other drivers of chemoresistance in small cell lung cancer
GEO Series GSE255095. Homo sapiens. 67 samples. Type: Expression profiling by high throughput sequencing.
In vivo multiplexed screen reveals a critical role of Keap1/Nrf2 pathway in small cell lung cancer [RNAseq]
GEO Series GSE239436. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Identification of Ankrd35 as a mediator of cisplatin response in non-small cell lung cancer by in vivo screening of murine tumor derived xenografts
GEO Series GSE136317. Mus musculus. 32 samples. Type: Non-coding RNA profiling by high throughput sequencing.
In vivo CRISPR Screening Identifying Therapeutic Target to Sensitize Anti-PD-1 Immunotherapy in Non-small Cell Lung Cancer
GEO Series GSE301822. Mus musculus. 72 samples. Type: Other.
Identification of Ankrd35 as a mediator of cisplatin response in non-small cell lung cancer by ex vivo 3D screening of primary tumor spheroids
GEO Series GSE136346. Mus musculus. 412 samples. Type: Expression profiling by array; Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing.
Identification of Ankrd35 as a mediator of cisplatin response in non-small cell lung cancer by ex vivo 3D screening of primary tumor spheroids
GEO Series GSE136316. Mus musculus. 350 samples. Type: Non-coding RNA profiling by high throughput sequencing.
In vivo multiplexed screen reveals a critical role of Keap1/Nrf2 pathway in small cell lung cancer [TUBAseq]
GEO Series GSE239440. Mus musculus. 6 samples. Type: Other.
In vivo multiplexed screen reveals a critical role of Keap1/Nrf2 pathway in small cell lung cancer
GEO Series GSE239441. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing; Other.
Dataset related to article "Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomography."
<p>AIM:</p> <p>The aim of this study was to analyze the economic efficiency of second-line diagnostic investigations in patients with undetermined lung nodules.</p> <p>PARTICIPANTS AND METHODS:</p> <p>A retrospective review of all surgical cases included in the DANTE trial from 2001 to 2006 for lung cancer screening was performed. Overall, 217 patients and 261 lung nodules were analyzed. The cohort was divided into patients investigated with PET and/or computed tomography (CT)-guided biopsy (PET-CTB protocol; N=100), compared with those assessed with serial low-dose CT scans (standard protocol; N=161). Outpatient's and inpatient's costs were expressed in euros and derived from the Italian National Health Service. Ineffective costs were defined as the cost of procedures that lead to avoidable surgical intervention.</p> <p>RESULTS:</p> <p>The diagnostic accuracy of the two protocols was 91% for the standard (sensitivity 100%, specificity 91%, positive predictive value 26%, and negative predictive value 100%) and 90% for the PET-CTB protocol (sensitivity 98%, specificity 81%, positive predictive value 85%, and negative predictive value 97%). Average costs for outpatient's diagnostics were 694 and 1.462 euros, respectively, for the standard and PET-CTB protocol. Average inpatient's costs for both protocols were 12.121 euros. The two protocols showed comparable effectiveness in terms of outpatient's costs (94 and 90%, respectively; P=0.252). Inpatient's costs were effective in 36% of cases monitored according to the standard protocol compared with 85% of patients investigated with PET-CTB protocol. Ineffective costs corresponded to 64 and 15%, respectively (P<0.0001).</p> <p>CONCLUSION:</p> <p>Despite a higher average cost for outpatient's diagnostics, the implementation of PET imaging with or without CT-guided needle biopsy in the workup of suspicious lung nodules results in reduced unnecessary harm and costs related to inpatient's procedures.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.